Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.331 $0.440 Thursday, 9th May 2024 GLMD stock ended at $0.415. This is 6.71% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 13.51% from a day low at $0.370 to a day high of $0.420.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
Jan 03, 2017 $3.52 $3.69 $3.43 $3.63 19 135
Dec 30, 2016 $3.74 $3.74 $3.37 $3.51 113 495
Dec 29, 2016 $3.67 $3.88 $3.66 $3.74 47 456
Dec 28, 2016 $3.70 $3.83 $3.54 $3.67 58 152
Dec 27, 2016 $3.70 $3.77 $3.57 $3.65 35 256
Dec 23, 2016 $3.58 $3.67 $3.54 $3.67 11 058
Dec 22, 2016 $3.50 $3.72 $3.50 $3.59 14 959
Dec 21, 2016 $3.89 $3.89 $3.57 $3.74 23 185
Dec 20, 2016 $3.65 $4.06 $3.65 $3.79 213 953
Dec 19, 2016 $3.16 $3.40 $3.16 $3.40 29 108
Dec 16, 2016 $3.13 $3.37 $3.13 $3.16 19 885
Dec 15, 2016 $3.17 $3.24 $3.04 $3.12 24 975
Dec 14, 2016 $3.22 $3.27 $3.15 $3.21 17 856
Dec 13, 2016 $3.22 $3.29 $3.19 $3.27 42 117
Dec 12, 2016 $3.36 $3.47 $3.24 $3.24 23 433
Dec 09, 2016 $3.64 $3.65 $3.29 $3.29 17 693
Dec 08, 2016 $3.43 $3.68 $3.40 $3.51 26 649
Dec 07, 2016 $3.50 $3.63 $3.27 $3.38 10 432
Dec 06, 2016 $3.23 $3.55 $3.23 $3.46 23 567
Dec 05, 2016 $3.68 $3.68 $3.42 $3.49 24 594
Dec 02, 2016 $3.55 $3.73 $3.55 $3.72 7 683
Dec 01, 2016 $3.56 $3.56 $3.38 $3.55 17 707
Nov 30, 2016 $3.65 $3.73 $3.38 $3.51 17 503
Nov 29, 2016 $3.65 $3.74 $3.59 $3.62 21 061
Nov 28, 2016 $3.71 $3.95 $3.48 $3.68 37 492
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT